COVID 19: Camostat and the Role of Serine Protease Entry Inhibitor TMPRSS2

Journal Title: Journal of Regenerative Biology and Medicine - Year 2020, Vol 2, Issue 2

Abstract

According to the latest research, the novel coronavirus uses the protein angiotensin-converting enzyme 2 (ACE-2) as a receptor for docking to the host cell. Essential for entry is the priming of the spike (S) protein of the virus by host cell proteases. A broadly based team led by infection biologists from the German Primate Centre and with the participation of the Charité Hospital in Berlin, the Hanover Veterinary University Foundation, the BG-UnfallklinikMurnau, the LMU Munich, the Robert Koch Institute and the German Centre for Infection Research wanted to find out how SARS-CoV-2 enters host cells and how this process can be blocked [1]. They have published their findings in the journal "Cell" [1]. The team of scientists was initially able to confirm that SARS-CoV-2 docks to the host cell via the ACE-2 receptor. They also identified Transmembrane serine protease 2 (TMPRSS2) as the cellular protein responsible for entry into the cell [1-3].

Authors and Affiliations

Stefan Bittmann*, Elisabeth Luchter, Elena Moschüring-Alieva, Gloria Villalon, Anne Weissenstein

Keywords

Related Articles

The Future of Medicine - Biologics and Artificial Intelligence

The future of medicine is in biologics and artificial intelligence AI. With the advent of advancing and disruptive technologies, many traditional therapies are being replaced by new therapies such as: stem cell therapy,...

Allogenic Human Umbilical Cord Derived Mesenchymal Stem Cells for Managing Knee Osteoarthritis in Human - A Clinical Trial

Introduction: Human Mesenchymal Stem Cell has been scientifically accepted as a method of managing Osteoarthritis in the Human knee. They can be derived from Autologous Bone Marrow, Adipose Tissue, and less commonly Syno...

Preliminary Experience of Video Conferences in Pediatrics in Covid-19 Pandemic

A video conference enables real-time exchange between two or more participants at different locations via audio and video communication. In terms of the visualization of the discussion partners, a videoconference thus di...

Front-line Healthcare Workers in COVID-19: The way from Elbow-Bump Greeting to Closing Body Bags

COVID-19 is a serious coronavirus disease that is spreading all over the world. As of the date of this publication, 2.834.134 people have been infected with COVID-19 and 197.924 deaths have been recorded in 185 countries...

First-level Neurocognitive Screening Tests and their Application

In June 2021, the Food and Drug Administration approved Aducanumab for the treatment of Alzheimer’s disease – the most common cause of dementia worldwide [1]. This drug is a monoclonal antibody that would be cause amylo...

Download PDF file
  • EP ID EP707323
  • DOI https://doi.org/10.37191/Mapsci-2582-385X-2(2)-020
  • Views 57
  • Downloads 0

How To Cite

Stefan Bittmann*, Elisabeth Luchter, Elena Moschüring-Alieva, Gloria Villalon, Anne Weissenstein (2020). COVID 19: Camostat and the Role of Serine Protease Entry Inhibitor TMPRSS2. Journal of Regenerative Biology and Medicine, 2(2), -. https://europub.co.uk/articles/-A-707323